
Medical Research Council
Also known as: Anna Griffiths, MRC | British Medical Research Council | Cheryl Pugh | dora pereira | Justine Boles | Medical Research Council | Medical Research Council CTU | Medical Research Council @ LSHTM | Medical Research Council (MRC) / Uganda Virus Research Institute (UVRI) | Medical Research Council-Oxford | Medical Research Council Population Health Research Unit | Medical Research Council Social & Public Health Sciences Unit, UK | Medical Research Council/Uganda Viral Research Institute (UVRI) Uganda Research Unit on AIDS, UVRI/International AIDS Vaccine Initiative HIV Vaccine Program | MRC Clinical Trials Unit | MRC CTU | MRC CTU at UCL | MRCCTU at UCL is coordinating the trial | MRC Entebbe | MRC Health Services Research Collaboration | MRC HNR | MRC Human Nutrition Research | MRC Laboratories | MRC Laboratories, Faraffeni, The Gambia | MRC laboratories, Gambia | MRC Laboratories, Gambia | MRC Laboratories, The Gambia | MRC Myelomatosis Trials Office | MRC Prion Unit | MRC UK Biostatistics Unit | MRC (UK) Laboratories, The Gambia | MRC Unit, Fajara The Gambia | MRC/UVRI & LSHTM Uganda Research Unit | MRC /UVRI Uganda Research Unit on AIDS, Entebbe, Uganda | MRC/UVRI Unit | MRC [ycm] | National Institute for Medical Research | Professor David Cunningham
Highest phase reached
Phase 4
First clinical trial
Apr 1, 1991Last known activity
Nov 11, 2025
Timeline
1910s
- Jan 1, 1913
Medical Research Council— Founded
Drugs by trial phase (302 distinct, 234 trials)
Phase 4 (53 own, 0 via acquisition)
Phase 3 (130 own, 0 via acquisition)
Phase 2 (65 own, 0 via acquisition)
Phase 1 (40 own, 0 via acquisition)
Other trials (14 own, 0 via acquisition)
Indications
Studied for
- Abdominal Pain
- Acquired Immunodeficiency Syndrome
- Acute Kidney Injury
- Acute Pain
- Adenocarcinoma
- Alzheimer Disease
- Amyloidosis
- Anemia
- Anemia, Aplastic
- Anemia, Iron-Deficiency
- Anemia, Sickle Cell
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- Asthma
- Bone Marrow Diseases
- Brain Injuries
- Breast Neoplasms
- Burkitt Lymphoma
- Cachexia
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Transitional Cell
- Cardiomyopathies
- Cardiomyopathy, Hypertrophic
- Central Nervous System Neoplasms
- Chlamydia Infections
- Chronic Disease
- Churg-Strauss Syndrome
- Cicatrix
- Colorectal Neoplasms
- Common Cold
- Communicable Diseases
- Constipation
- Coronavirus Infections
- Critical Illness
- Crohn Disease
- Dental Caries
- Depression
- Depressive Disorder
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diarrhea
- Disease
- Eczema
- Esophageal Neoplasms
- Fallopian Tube Neoplasms
- Familial Primary Pulmonary Hypertension
- Fatigue
- Fatigue Syndrome, Chronic
- Fatty Liver
- Fever
- Flushing
- Glioblastoma
- Glioma
- Gliosarcoma
- Gonorrhea
- Graft vs Host Disease
- Granulomatosis with Polyangiitis
- Heartburn
- Hematologic Neoplasms
- Hemophilia A
- Hemorrhage
- Herpes Genitalis
- HIV Infections
- HIV Seropositivity
- Hodgkin Disease
- Hot Flashes
- Hypersensitivity
- Hypertension
- Hypertension, Pulmonary
- Hypertrophy
- Immunologic Deficiency Syndromes
- Infarction
- Infections
- Inflammation
- Influenza, Human
- Invasive Fungal Infections
- Kidney Diseases
- Kidney Neoplasms
- Latent Tuberculosis
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Lymphoma
- Malaria
- Malaria, Falciparum
- Measles
- Meniere Disease
- Meningitis
- Meningitis, Cryptococcal
- Meningitis, Fungal
- Mesothelioma
- Microscopic Polyangiitis
Recent trials (50)
- NCT07300683CollaboratorPhase 1Nov 11, 2025
- NCT06921213CollaboratorPhase 2Oct 1, 2025
- NCT07207057CollaboratorPhase 3Sep 12, 2025
- NCT06626984CollaboratorPhase 1/Phase 2Dec 1, 2024
- NCT06676384CollaboratorPhase 4Nov 30, 2024
- NCT06320067OfficialPhase 3Jun 11, 2024
- NCT06324669CollaboratorN/AMar 16, 2024
- NCT06560853CollaboratorN/AFeb 27, 2024
- NCT05898633CollaboratorPhase 1Dec 31, 2023
- NCT05600062CollaboratorN/AJan 16, 2023
- NCT05491135CollaboratorPhase 1/Phase 2Sep 30, 2022
- NCT05085028CollaboratorPhase 3Jun 1, 2022
- NCT05397184CollaboratorPhase 1Apr 19, 2022
- NCT04913025Study directorPhase 2Oct 31, 2021
- NCT04934111Overall official - principal investigatorPhase 1Sep 30, 2021
Details
- Founded
- Swindon, GB Jan 1, 1913
- Last known activity
- Nov 11, 2025